SEC Filings - Bolt Biotherapeutics

Filing date	Description	Form	Filing Group	View
December 16, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	0001564590-21-060502.pdf 0001564590-21-060502.rtf 0001564590-21-060502.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 16, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0000899243-21-048600.pdf 0000899243-21-048600.rtf 0000899243-21-048600.xls View HTML
December 16, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-21-048601.pdf 0000899243-21-048601.rtf 0000899243-21-048601.xls View HTML
December 9, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-21-047518.pdf 0000899243-21-047518.rtf 0000899243-21-047518.xls View HTML
December 6, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	0001564590-21-059379.pdf 0001564590-21-059379.rtf 0001564590-21-059379.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 29, 2021	A statement of beneficial ownership of common stock by certain persons	SC 13G	Other	0000919574-21-007267.pdf 0000919574-21-007267.rtf 0000919574-21-007267.xls View HTML
November 22, 2021	An amendment to a SC 13D filing	SC 13D/A	Other	0001193125-21-336745.pdf 0001193125-21-336745.rtf 0001193125-21-336745.xls View HTML
November 19, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	0001564590-21-057696.pdf 0001564590-21-057696.rtf 0001564590-21-057696.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 19, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001209191-21-065884.pdf 0001209191-21-065884.rtf 0001209191-21-065884.xls View HTML
November 19, 2021	Statement of changes in beneficial ownership of securities	4	3,4,5	0001209191-21-065887.pdf 0001209191-21-065887.rtf 0001209191-21-065887.xls View HTML

Data provided by Kaleidoscope.